Pathogenesis, treatment options and outcomes for antiphospholipid syndrome (APS) are poorly defined. A new observational collaborative study has analysed morbidity and mortality in APS, but, ultimately, the data that will guide us to optimally treat patients with APS are lacking. Here we provide a construct for future large-scale collaborative studies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cervera, R. et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-204838 (2014).
Erkan, D., Yazici, Y., Sobel, R. & Lockshin, M. D. Primary antiphospholipid syndrome. functional outcome after 10 years. J. Rheumatol. 27, 2817–2821 (2000).
Singh, N. K. et al. Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti-phospholipid syndrome. Int. J. Rheum. Dis. 16, 547–555 (2013).
Arnaud, L. et al. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis. Autoimmun. Rev. 13, 281–291 (2014).
Lockshin, M. D. et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum. 64, 2311–2318 (2012).
Giannakopoulos, B. & Krilis, S. A. The pathogenesis of the antiphospholipid syndrome. N. Engl. J. Med. 368, 1033–1044 (2013).
Erkan, D. et al. 14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends. Autoimmun. Rev. http://dx.doi.org/10.1016/j.autrev.2014.01.053.
Erkan, D., Lockshin, M. D. & APS ACTION members. APS ACTION—antiphospholipid syndrome alliance for. clinical trials and international networking. Lupus 21, 695–698 (2012).
Harris, E. N. et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2, 1211–1214 (1983).
Acknowledgements
This work is supported by the Barbara Volcker Centre for Women and Rheumatic Diseases.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Erkan, D., Lockshin, M. Antiphospholipid syndrome research needs more collaboration. Nat Rev Rheumatol 10, 266–267 (2014). https://doi.org/10.1038/nrrheum.2014.39
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.39
